A randomized phase 3 trial of paclitaxel (P) plus carboplatin (C) versus paclitaxel plus ifosfamide (I) in chemotherapy-naive patients with stage I-IV, persistent or recurrent carcinosarcoma of the uterus or ovary: An NRG Oncology trial Meeting Abstract
| Authors: | Powell, M. A.; Filiaci, V. L.; Hensley, M. L.; Huang, H. Q.; Moore, K. N.; Tewari, K. S.; Copeland, L. J.; Secord, A. A.; Mutch, D. G.; Santin, A.; Richards, W.; Warshal, D. P.; Spirtos, N. M.; Disilverstro, P.; Ioffe, O.; Miller, D. S. |
| Abstract Title: | A randomized phase 3 trial of paclitaxel (P) plus carboplatin (C) versus paclitaxel plus ifosfamide (I) in chemotherapy-naive patients with stage I-IV, persistent or recurrent carcinosarcoma of the uterus or ovary: An NRG Oncology trial |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 314s |
| Language: | English |
| ACCESSION: | WOS:000487345805493 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.5500 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5500 -- Source: Wos |
